News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR professor is a 'Game Changer' in Woman’s Hour Power List
Professor Nazneen Rahman, head of the Division of Genetics and Epidemiology, has been announced as one of the top ten 'Game Changers' in the BBC Woman's Hour Power List of 2014.
ICR researcher wins award to present at top cancer conference
A young scientist at The Institute of Cancer Research, London, is presenting her work at a leading international cancer conference after winning a major award for early-career researchers.
Stopping cancer in its tracks: the ICR’s Discovery Club tackles cancer metastasis
Our latest Discovery Club event at the Royal Society gave members and guests an insight into a crucial area of our research: understanding how cancer cells spread around the body.
Video: Dr Chris Jones on the discovery of the genetic flaw that may hold the key to devastating childhood cancer
Dr Chris Jones tells Henry French about his team's discovery of a genetic flaw driving the deadly childhood brain cancer DIPG, its surprising links to a developmental syndrome in which muscle turns to bone, and how the discovery could lead to new therapies for this hard-to-treat cancer
Genetic flaw may hold key to deadly childhood brain tumour
ICR researchers have found a surprising link between childhood glioma and rare genetic syndrome in which muscle turns to bone.
ICR researchers focus on smart treatments at leading cancer conference
ICR scientists are making the trip to San Diego this weekend for one of the biggest dates in the cancer calendar – the American Association of Cancer Research (AACR) conference.
Blood test could provide a representative measure of long term hormone levels
A single blood sample could predict hormone levels known to be an indicator of breast cancer risk for years to come, according to ICR researchers.
How cancer evolves sheds light on origin of breast cancer subtypes
ICR researchers find that multiple forms of breast cancer can originate from a single cell type, which could change how we target and treat the disease.
Statement in reaction to new proposals from NICE on end of life criteria
The ICR highlights the importance of the end of life criteria in the way NICE makes recommendations on new medicines, as it is important for cancer patients to access life-extending drugs.
High-tech ultrasound scan could match tumour tracking power of CyberKnife
A new type of ultrasound imaging could potentially follow tumour movements as well as the X-ray tracking used in the sophisticated radiotherapy technology CyberKnife, allowing precise targeting of radiation doses, new research concludes.
Gut bacteria clinical study could help reduce radiotherapy side-effects
ICR researchers will examine how gut bacteria influences the side-effects patients experience after radiotherapy, in the first clinical study of its type.
Professor Andrew Tutt to head Breakthrough Breast Cancer Research Centre
Leading expert in clinical trials and targeted therapies for breast cancer joins the ICR as Centre Director for the Breakthrough Toby Robins Breast Cancer Research Centre.
